Castle Biosciences Newsroom

Castle Biosciences Is Maintained at Sector Outperform by Scotiabank

Dow JonesNov 7 00:01

Castle Biosciences Analyst Ratings

BenzingaNov 6 23:51

Scotiabank Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44

Futu NewsNov 6 21:31

Strong Growth Prospects and Financial Health Support Buy Rating for Castle Biosciences

TipRanksNov 6 16:21

BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $45

Futu NewsNov 6 05:33

Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $40

Futu NewsNov 5 22:35

Castle Biosciences (CSTL) Gets a Buy From Lake Street

TipRanksNov 5 22:02

CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $42

Futu NewsNov 5 20:36

Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $39

Futu NewsNov 5 20:36

Castle Biosciences Is Maintained at Outperform by Baird

Dow JonesNov 5 20:09

Castle Biosciences Analyst Ratings

BenzingaNov 5 19:59

KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $36

Futu NewsNov 5 18:33

Castle Biosciences Is Maintained at Buy by Canaccord Genuity

Dow JonesOct 29 20:29

Castle Biosciences Analyst Ratings

BenzingaOct 29 20:18

CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $42

Futu NewsOct 29 19:31

Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $34

Futu NewsOct 16 21:35

BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $40

Futu NewsOct 15 18:31

Castle Biosciences' TissueCypher Gains Buy Rating Due to Market Potential and Medicare Reimbursement

TipRanksOct 15 18:19

Castle Biosciences Is Maintained at Buy by BTIG

Dow JonesOct 14 23:21

Castle Biosciences Analyst Ratings

BenzingaOct 14 23:12